Crescent Biopharma, Inc.
CBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,607 | -$21,790 | -$2,344 | -$37,879 |
| Dep. & Amort. | $0 | $2 | $0 | $35,139 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $1,160 |
| Change in WC | $4,974 | $4,060 | -$3,168 | $2,391 |
| Other Non-Cash | $2,108 | -$4,433 | $405 | -$4,512 |
| Operating Cash Flow | -$17,525 | -$22,161 | -$5,106 | -$3,701 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$586 | -$140 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $30 |
| Investing Cash Flow | -$586 | -$140 | $0 | $30 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14 | $14 | $0 | $0 |
| Stock Issued | $0 | $5 | $0 | $0 |
| Stock Repurch. | $0 | -$177 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,254 | $145,550 | $0 | $0 |
| Financing Cash Flow | -$1,268 | $145,392 | $0 | $0 |
| Forex Effect | -$1 | $23,940 | $0 | $0 |
| Net Chg. in Cash | -$19,380 | $147,031 | -$5,106 | -$3,671 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $152,645 | $5,614 | $10,720 | $14,392 |
| End Cash | $133,265 | $152,645 | $5,614 | $10,720 |
| Free Cash Flow | -$18,111 | -$22,301 | -$5,106 | -$3,701 |